tirzepatide weight loss trial versus Semaglutide Once Weekly in Patients with Type 2 Diabetes New clinical trial: Zepbound (tirzepatide)

306 Combination strategies using -lipoic acid and hydroxycitrate enhance catabolic metabolism and suppress tumor growth in glioblastoma, brain metastases, and lung cancer

In the KEYNOTE-355 trial, pembrolizumab combined with chemotherapy significantly extends OS in patients with metastatic TNBC with a CPS 10, making it the first immunotherapy to achieve this

The condition exists in two primary forms: metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease or NAFLD), which affects individuals who consume little to no alcohol, and alcoholic fatty liver disease

Daily Variations Are Normal Urine color is not static